The effects of low-density lipoprotein (LDL) and chylomicron remnants on lipid accumulation in human monocyte–derived macrophages (HMDMs) and in macrophages derived from the human monocyte cell line THP-1 were compared. The HMDMs or THP-1 macrophages were incubated with LDL, oxidized LDL (oxLDL), chylomicron remnant–like particles (CMR-LPs), or oxidized CMR-LPs (oxCMR-LPs), and the amount and type of lipid accumulated were determined. As expected, the lipid content of both cell types was increased markedly by oxLDL but not LDL, and this was due to a rise in cholesterol, cholesteryl ester (CE), and triacylglycerol (TG) levels. In contrast, both CMR-LPs and oxCMR-LPs caused a considerable increase in cellular lipid in HMDMs and THP-1 macrophages, but in this case there was a greater rise in the TG than in the cholesterol or CE content. Lipid accumulation in response to oxLDL, CMR-LPs, and oxCMR-LPs was prevented by the ACAT inhibitor CI976 in HMDMs but not in THP-1 macrophages, where TG levels remained markedly elevated. The rate of incorporation of [3H]oleate into CE and TG in THP-1 macrophages was increased by oxLDL, CMR-LPs, and oxCMR-LPs, but incorporation into TG was increased to a greater extent with CMR-LPs and oxCMR-LPs compared with oxLDL. These results demonstrate that both CMR-LPs and oxCMR-LPs cause lipid accumulation in human macrophages comparable to that seen with oxLDL and that oxidation of the remnant particles does not enhance this effect. They also demonstrate that a greater proportion of the lipid accumulated in response to CMR-LPs compared with oxLDL is TG rather than cholesterol or CE and that this is associated with a higher rate of TG synthesis. This study, therefore, provides further evidence to suggest that chylomicron remnants have a role in foam cell formation that is distinct from that of oxLDL.
SteinbergD. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem272: 20963–20966, 1997.
4.
NapolitanoM. Rivabene R, Avella M, Botham KM, Bravo E. The internal redox balance of cells influences the metabolism of lipids of dietary origin by J774 macrophages: implications for foam cell formation. J Vasc Res38: 350–360, 2001.
5.
YuKC, MamoJC. Chylomicron remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin Sci (London)98: 183–192, 2000.
6.
RedgraveTG. Formation and metabolism of chylomicrons. Int Rev Physiol28: 103–130, 1983.
7.
MamoJC, ProctorSD, SmithD. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis141(suppl 1):S63–S69, 1998.
8.
ProctorSD, MamoJCL. Retention of fluorescent-labelled chylomicron remnants within the intima of the artery wall - evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest28: 497–503, 1998.
9.
GrieveDJ, AvellaMA, ElliottJ, BothamKM. Influence of chylomicron remnants on endothelial cell function in the isolated perfused rat aorta. Atherosclerosis139: 273–281, 1998.
10.
MamoJCL, WheelerJR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low density lipoprotein, high density lipoprotein and albumin. Coronary Artery Dis5: 695–705, 1994.
11.
Yla-HerttualaS, JaakkolaO, EnholmC, TikkanenMJ, SolakiviT, SarkiojaT, NikkariT. Characterisation of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res29: 563–572, 1988.
12.
RappJH, LespineA, HamiltonRL, ColyvasN, ChaumetonAH, Tweedie-HarmanJ, KotiteL, KunitakeST, HavelRJ, KaneJP. Triglyceride-rich lipoproteins isolated by selective affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb14: 1767–1774, 1994.
13.
BenlianP, De GennesPL, FoubertL, ZhangH, GagneSE, HaydenM. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med335: 848–854, 1996.
14.
GrootPHE, van StiphoutWAH, KraussXH, JansenH, van TolA, van RamshorstE, Chin-OnS, HofmannA, CresswellSR, HavekesL. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary heart disease. Arterioscler Thromb11: 653–662, 1991.
15.
GianturcoSH, BrownSA, ViaDP, BradleyWA. The β-VLDL receptor pathway of murine P388D1 macrophages. J Lipid Res27: 412–420, 1986.
16.
MilosavljevicD, KontushA, GriglioS, Le NaourG, ThilletJ, ChapmanMJ. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim Biophys Acta1631: 51–60, 2003.
17.
DiardP, MalewiakM-I, LagrangeD, GriglioS. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem J299: 889–894, 1994.
18.
NapolitanoM, BattKV, AvellaM, BravoE, BothamKM. Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidised chylomicron remnant-like particles by estrogen. Clin Sci (London)101: 403–413, 2001.
19.
LenzoNP, MartinsI, MortimerIBC, RedgraveTG. Effects of phospholipid composition on the metabolism of triacylglycerol, cholesteryl ester and phosphatidylcholine from lipid emulsions injected intravenously into rats. Biochim Biophys Acta960: 111–118, 1998.
20.
AndersonLJ, BoylesJK, HussainMM. A rapid method for staining large chylomicrons. J Lipid Res30: 1819–1824, 1989.
21.
SchmitzG, AssmannG, BowyerDE. A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high-performance thin-layer chromatography, I: sample preparation, chromatography, and densitometry. J Chromatogr307: 65–79, 1984.
22.
SteinbrecherUP, ParthasarathyS, LeakeDS, WitzumJL, SteinbergD. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A81: 3883–722, 1984.
23.
LaemmliUK. Cleavage of structural protein during assembly of the head of bacteriophage T4. Nature227: 680–685, 1970.
24.
LowryOH, RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the protein phenol reagent. J Biol Chem58: 4606–4611, 1951.
25.
RyeKA, ClayMA, BarterPJ. Overview of plasma lipid transport. In: BarterPJ, RyeKA, Eds. Plasma Lipids and Their Role in Disease. Australia:Harwood Academic Publishers, pp 1–16, 1999.
26.
KrauseBR, AndersonM, BisgaierCL, BocanT, BousleyR, DeHartP, EssenburgA, HamelehleK, HomanR, KieftK, McNallyW, StanfieldR, NewtonRS. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J Lipid Res34: 279–294, 1993.
27.
RedgraveTG, FidgeNH, YinJ. Specific, saturable binding and uptake of rat chylomicron remnants by rat skin fibroblasts. J Lipid Res23: 638–644, 1982.
28.
RedgraveTG, LyHL, QuintaoCR, RambergCF, BostonR. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochem J290: 843–847, 1993.
29.
MaranhaoRC, FersMC, MartinsMT, MesquitaCH, ToffolettoO, VinagreCGC, GianinniSD, PileggiF. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis126: 15–25, 1996.
30.
OliveiraHC, HirataMH, RedgraveTG, MaranhaoRC. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons. Biochim Biophys Acta958: 211–217, 1988.
31.
MartinsIJ, VermeulenR, RedgraveTG. Relative roles of mitochondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test. Atherosclerosis150: 13–20, 2000.
32.
SultanF, LagrangeD, Le LiepvreX, GriglioS. Chylomicron remnant uptake by freshly isolated hepatocytes: effects of heparin and of hepatic triacylglycerol lipase. Biochem J258: 587–594, 1989.
ThurenT, SissonP, WaiteM. Hydrolysis of lipid mixtures by rat hepatic lipase. Biochim Biophys Acta1083: 217–220, 1991.
35.
AuwerxJ. The human leukaemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia47: 22–31, 1991.
36.
GoldsteinJL, HoYK, BasuSK, BrownMS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A7: 333–337, 1979.
37.
HeineckeJW. Free radical modification of low-density lipoprotein: mechanisms and biological consequences. Free Radic Biol Med3: 65–73, 1987.
38.
AviramM. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem267: 218–225, 1992.
39.
ProctorSD, VineDF, MamoJCL. Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol13: 461–470, 2002.
40.
NapolitanoM, AvellaM, BothamKM, BravoE. Chylomicron remnant induction of lipid accumulation in J774 macrophages is associated with up-regulation of triacylglycerol synthesis which is not dependent on oxidation of the particles. Biochim Biophys Acta1631: 255–264, 2003.
41.
IshiiI, OnozakiR, TakahashiE, TakahashiS, FujioN, HaradaT, MorisakiN, ShiraiK, SaitoY, HiroseS. Regulation of neutral cholesterol esterase activity by phospholipases containing negative charges in substrate liposome. J Lipid Res36: 2303–2310, 1995.
42.
NishikawaK, AraiH, InoueK. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem265: 5226–5231, 1990.
43.
KritharidesL, ChristianA, StoudtG, MorelD, RothblatG. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler Thromb Vasc Biol18: 1589–1599, 1998.
44.
LadaAT, WillinghamMC, ClairRW. Triglyceride depletion in THP-1 cells alters cholesteryl ester physical state and cholesterol efflux. J Lipid Res43: 618–628, 2002.
45.
SinzMW, BlackAE, BjorgeSM, HolmesA, TrivediBK, WoolfTF. In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6 trimethoxyphenyl) dodecanamide (CI-976): identification of a novel five-carbon cleavage metabolite in rats. Drug Metab Dispos25: 123–130, 1997.
46.
KogushiM, TanakaH, KobayashiH, YamadaT, OhtsukaI, KimuraT, SaitoI. Effect of E5324, a novel inhibitor of acyl-CoA: cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages. Jpn J Pharmacol68: 191–199, 1995.
47.
MurakamiS, YamagishiI, AsamiY, SatoM, TomisawaK. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages. Cell Mol Biol42: 865–872, 1996.
48.
AzumaY, KawasakiT, IkemotoK, OhnoK, YamadaT, YamasakiM, NobuharaY. Effects of NTE-122, a novel acyl-CoA: cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages. Jpn J Pharmacol79: 159–167, 1999.
49.
RodriguezA, BachorikPS, WeeSB. Novel effects of the acylcoenzyme A: cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol19: 2199–2206, 1999.
50.
BrownMS, HoYK, GoldsteinJL. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J Biol Chem255: 9344–9352, 1980.
51.
KnightBL, SoutarAK, PatelDD. Non-saturable degradation of LDL by monocyte-derived macrophages leads to a reduction in HMG-CoA reductase activity with little synthesis of cholesteryl esters. Atherosclerosis64: 131–138, 1987.
52.
YuKC-W, MamoJCL. Regulation of cholesterol synthesis and esterification in primary cultures of macrophages following uptake of chylomicron remnants. Biochem Mol Biol Int41: 33–39, 1997.
53.
KumeN, KitaT. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol12: 419–423, 2001.
54.
EllsworthJL, KraemerFB, CooperAD. Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem262: 2316–2325, 1987.
55.
ElsegoodCL, PalS, RoachPD, MamoJC. Binding and uptake of chylomicron remnants by primary and THP-1 monocyte-derived macrophages: determination of binding proteins. Clin Sci (London)101: 111–119, 2001.
56.
BrownML, RamprasadMP, UmedaPK, TanakaA, KobayashiY, WatanabeT, ShimoyamadaH, KuoWL, LiR, SongR, BradleyWA, GianturcoSH. A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proc Natl Acad Sci U S A97: 7488–7493, 2000.
